{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "currency": "USD", "market": "us_market", "esgPopulated": false, "gmtOffSetMilliseconds": -14400000, "exchange": "NMS", "longName": "Ventyx Biosciences, Inc.", "shortName": "Ventyx Biosciences, Inc.", "regularMarketPrice": 34.9, "regularMarketChangePercent": -7.1067295, "messageBoardId": "finmb_672535556", "marketState": "PRE", "fiftyTwoWeekHighChangePercent": -0.26139125, "fiftyTwoWeekLow": 11.07, "fiftyTwoWeekHigh": 47.251, "earningsTimestamp": 1683837000, "earningsTimestampStart": 1683837000, "earningsTimestampEnd": 1683837000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 23.830002, "fiftyTwoWeekLowChangePercent": 2.1526651, "fiftyTwoWeekRange": "11.07 - 47.251", "fiftyTwoWeekHighChange": -12.350998, "epsTrailingTwelveMonths": -1.83, "epsForward": -3.08, "epsCurrentYear": -2.75, "priceEpsCurrentYear": -12.690909, "sharesOutstanding": 58479400, "bookValue": 6.211, "fiftyDayAverage": 36.4878, "fiftyDayAverageChange": -1.5877991, "fiftyDayAverageChangePercent": -0.043515887, "twoHundredDayAverage": 32.252026, "twoHundredDayAverageChange": 2.647976, "twoHundredDayAverageChangePercent": 0.08210263, "marketCap": 2309936896, "forwardPE": -11.33117, "priceToBook": 5.6190634, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-21", "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1634823000000, "priceHint": 2, "regularMarketChange": -2.6699982, "regularMarketTime": 1683921604, "regularMarketDayHigh": 38.63, "regularMarketDayRange": "34.495 - 38.63", "regularMarketDayLow": 34.495, "regularMarketVolume": 949638, "regularMarketPreviousClose": 37.57, "bid": 32.82, "ask": 54.46, "bidSize": 31, "askSize": 10, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 37.32, "averageDailyVolume3Month": 852836, "averageDailyVolume10Day": 642140, "displayName": "Ventyx Biosciences", "symbol": "VTYX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "662 Encinitas Blvd.", "address2": "Suite 250", "city": "Encinitas", "state": "CA", "zip": "92024", "country": "United States", "phone": "760-593-4832", "website": "https://ventyxbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. Its lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.", "fullTimeEmployees": 58, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sheila K. Gujrathi M.D.", "age": 52, "title": "Exec. Chairperson", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 125000, "fmt": "125k", "longFmt": "125,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Raju S. Mohan Ph.D.", "age": 64, "title": "Founder, CEO & Director", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 989992, "fmt": "989.99k", "longFmt": "989,992"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. William J. Sandborn M.D., Ph.D.", "age": 59, "title": "Pres & Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 872256, "fmt": "872.26k", "longFmt": "872,256"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1049691, "fmt": "1.05M", "longFmt": "1,049,691"}}, {"maxAge": 1, "name": "Dr. John M. Nuss Ph.D.", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 656990, "fmt": "656.99k", "longFmt": "656,990"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 12014213, "fmt": "12.01M", "longFmt": "12,014,213"}}, {"maxAge": 1, "name": "Dr. Martin Douglas Auster M.D.", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Christopher W. Krueger J.D., MBA", "age": 54, "title": "Chief Bus. Officer", "yearBorn": 1968, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 7, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}